Novas fronteiras em terapias endovasculares para carcinoma hepatocelular localmente avançado

O carcinoma hepatocelular é o tumor hepático maligno primário mais frequentemente observado, sendo uma das principais causas de mortalidade mundial. Apesar do advento dos programas de triagem, na maioria dos casos o diagnóstico tardio está associado a um estágio avançado da doença que impede o tratamento curativo, como cirurgia ou ablação. Assim, os tratamentos locorregionais intra-arteriais têm agora um papel central no gerenciamento avançado do carcinoma hepatocelular, passando por quimioembolização transarterial e radioembolização. Neste ensaio, discutimos o estado da arte do tratamento intra-arterial atualmente disponível para o carcinoma hepatocelular localmente avançado e suas direções futuras.

Unitermos:
Carcinoma hepatocelular/terapia; Fibrose; Fígado/patologia; Oncologia/métodos; Quimioembolização terapêutica; Neoplasias hepáticas/radioterapia

Autoria

Riccardo Inchingolo Correspondence: Riccardo Inchingolo, MD. Interventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy. Email: riccardoin@hotmail.it.

Interventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy."F. Miulli" Regional General HospitalItalyAcquaviva delle Fonti, BA, ItalyInterventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy.

Radiology Department, King's College Hospital, London, UK.King's College HospitalUKLondon, UKRadiology Department, King's College Hospital, London, UK.

http://orcid.org/0000-0002-0253-5936

Stavros Spiliopoulos

2nd Radiology Department, National and Kapodistrian University of Athens, Athens, Greece.National and Kapodistrian University of AthensGreeceAthens, Greece2nd Radiology Department, National and Kapodistrian University of Athens, Athens, Greece.

http://orcid.org/0000-0003-1860-0568

Alessandro Posa

Department of Radiology, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.Fondazione Policlinico Universitario A. GemelliItalyRome, ItalyDepartment of Radiology, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.

http://orcid.org/0000-0001-9617-3413

Tiago Kojun Tibana

Department of Interventional and Vascular Radiology, Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.Universidade Federal de Mato Grosso do SulBrazilCampo Grande, MS, BrazilDepartment of Interventional and Vascular Radiology, Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.

http://orcid.org/0000-0001-5930-1383

Thiago Franchi Nunes

http://orcid.org/0000-0003-0006-3725

Riccardo Memeo

Unit of Hepato-Pancreatic-Biliary Surgery, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy."F. Miulli" Regional General HospitalItalyAcquaviva delle Fonti, BA, ItalyUnit of Hepato-Pancreatic-Biliary Surgery, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy.

http://orcid.org/0000-0002-1668-932X

Correspondence: Riccardo Inchingolo, MD. Interventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy. Email: riccardoin@hotmail.it.

SCIMAGO INSTITUTIONS RANKINGS

Radiology Department, King's College Hospital, London, UK.King's College HospitalUKLondon, UKRadiology Department, King's College Hospital, London, UK.

Figuras

Figuras (4)

Thumbnail

Figure 1
Conventional TACE of a large HCC. Contrast-enhanced computed tomography scan of a 71-year-old patient with liver cirrhosis and a large (8 cm) HCC involving the right liver lobe (red arrow). Right hepatic artery branch digital subtraction angiography showing the hypervascular lesion. Follow-up contrast-enhanced computed tomography scan, acquired one month later, demonstrating a partial response, with tumour necrosis (white arrow), lipiodol deposition, and residual tumour in the lower part of the nodule (arrowhead).

Thumbnail

Figure 2
DSM-TACE of multi-nodular HCC. Contrast-enhanced computed tomography scan of a 75-year-old patient with liver cirrhosis and a multi-nodular HCC involving the right liver lobe, showing enhancement in the arterial phase (arrow). Note the right portal vein thrombosis (arrow). Right hepatic artery digital subtraction angiography showing the multi-nodular hypervascular lesion. Follow-up contrast-enhanced computed tomography scan, acquired one month later, demonstrating a partial response, with tumour necrosis and a thrombus remaining in the right branch of the portal vein (arrow).

Thumbnail

Figure 3
A 54-year-old male patient with alcoholic cirrhosis presenting with an HCC measuring 10 cm and located in the inferior left medial segment (segment IVb) of the liver. DEB-TACE was performed with HepaSphere 150-200 µm (Merit Medical Systems, South Jordan, UT, USA) loaded with doxorubicin 75 mg. Arteriography demonstrating the tumour blood supply originating from branches of the right hepatic artery and lateral branches of the gastro-duodenal artery. Microbubble contrast-enhanced ultrasound performed 24 h after the procedure, showing necrosis in > 90% of the embolised tumour.

Thumbnail

Figure 4
An 82-year-old male patient with an HCC, of the fibrolamellar subtype, measuring 18 cm and located in the right postero-inferior and postero-superior lateral segments (segments VI and VII, respectively) of the liver, as seen on an unenhanced magnetic resonance imaging scan. DEB-TACE of the liver tumour was performed with two vials of HepaSphere 150-200 µm (Merit Medical Systems, South Jordan, UT, USA) loaded with doxorubicin 75 mg. The patient evolved to an excellent general health status, with no signs of infection. A follow-up computed tomography scan, acquired one month later, showing 100% necrosis with intratumoural gas related to the tumour necrosis.

Figure 1 Conventional TACE of a large HCC. Contrast-enhanced computed tomography scan of a 71-year-old patient with liver cirrhosis and a large (8 cm) HCC involving the right liver lobe (red arrow). Right hepatic artery branch digital subtraction angiography showing the hypervascular lesion. Follow-up contrast-enhanced computed tomography scan, acquired one month later, demonstrating a partial response, with tumour necrosis (white arrow), lipiodol deposition, and residual tumour in the lower part of the nodule (arrowhead).

Figure 2 DSM-TACE of multi-nodular HCC. Contrast-enhanced computed tomography scan of a 75-year-old patient with liver cirrhosis and a multi-nodular HCC involving the right liver lobe, showing enhancement in the arterial phase (arrow). Note the right portal vein thrombosis (arrow). Right hepatic artery digital subtraction angiography showing the multi-nodular hypervascular lesion. Follow-up contrast-enhanced computed tomography scan, acquired one month later, demonstrating a partial response, with tumour necrosis and a thrombus remaining in the right branch of the portal vein (arrow).

Figure 3 A 54-year-old male patient with alcoholic cirrhosis presenting with an HCC measuring 10 cm and located in the inferior left medial segment (segment IVb) of the liver. DEB-TACE was performed with HepaSphere 150-200 µm (Merit Medical Systems, South Jordan, UT, USA) loaded with doxorubicin 75 mg. Arteriography demonstrating the tumour blood supply originating from branches of the right hepatic artery and lateral branches of the gastro-duodenal artery. Microbubble contrast-enhanced ultrasound performed 24 h after the procedure, showing necrosis in > 90% of the embolised tumour.

Figure 4 An 82-year-old male patient with an HCC, of the fibrolamellar subtype, measuring 18 cm and located in the right postero-inferior and postero-superior lateral segments (segments VI and VII, respectively) of the liver, as seen on an unenhanced magnetic resonance imaging scan. DEB-TACE of the liver tumour was performed with two vials of HepaSphere 150-200 µm (Merit Medical Systems, South Jordan, UT, USA) loaded with doxorubicin 75 mg. The patient evolved to an excellent general health status, with no signs of infection. A follow-up computed tomography scan, acquired one month later, showing 100% necrosis with intratumoural gas related to the tumour necrosis.

Como citar

copiar

Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem Av. Paulista, 37 - 7º andar - conjunto 71, 01311-902 - São Paulo - SP, Tel.: +55 11 3372-4541, Fax: 3285-1690, Fax: +55 11 3285-1690 - São Paulo - SP - Brazil
E-mail: radiologiabrasileira@cbr.org.br

Acompanhe os números deste periódico no seu leitor de RSS

Versão para download de PDF

PDF

Inglês

Versões e tradução automática

Versão original do texto

English

Tradução automática

Google Translator
Microsoft Translator

Como citar

RIS

BIBTEX

Outros formatos de citação e exportação:

SciELO - Scientific Electronic Library Online
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil
E-mail: scielo@scielo.org

Leia a Declaração de Acesso Aberto

Métricas

Novas fronteiras em terapias endovasculares para carcinoma hepatocelular localmente avançado

PlumX

Mensagem

[1] Correspondence: Riccardo Inchingolo, MD. Interventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva delle Fonti (BA), Italy. Email: riccardoin@hotmail.it.